This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stock Futures Climb with Chinese Growth Data

NEW YORK ( TheStreet) -- U.S. stock futures were rising Tuesday along with global markets as better-than-expected Chinese economic data assured investors the world's fastest-growing economy is for now safe from European debt woes.

Futures for the Dow Jones Industrial Average were up 93 points at 12,483. Futures for the S&P 500 were rising 11 points, or 15 points above fair value, at 1,300. Futures for the Nasdaq were gaining 20 points, or 25 points above fair value, to 2,394.

Chinese gross domestic product growth slowed to a rate of 8.9% in the fourth quarter, its slowest growth in 10 quarters, but better than the 8.7% expected by economists, according to a survey by Thomson Reuters. The Chinese statistics bureau also reported that industrial production increased 12.8% in December from a year earlier, a sign that China may yet avoid a hard landing provoked by declining demand from Europe.

Meanwhile, Greek citizens met in the capital Tuesday to protest European Union and International Monetary Fund interference in the country as the Mediterranean nation moved one step closer to a disorderly default. Greeks protested austerity measures as officials met in a race-against-the-clock meeting to pull together an agreement for a second bailout package before a bond payment comes due in late March.

Germany's DAX was up 1.7% while London's FTSE was up 0.7%. Japan's Nikkei Average settled 1.1% higher and Hong Kong's Hang Seng climbed 3.2%.

On the U.S. economic calendar, the Federal Reserve Bank of New York reported that manufacturing in the region rose more than forecast to its highest level since April. The Empire State Manufacturing Survey improved to 13.5 in January from a revised 8.2 in December for a third-straight increase after hovering in negative territory June through October. Economists had expected the measure to rise to 10.5, according to Thomson Reuters.

"The indicator was better than expected which continues the recent trend of generally improving macroeconomic indicators," Dan Greenhaus, chief gloal strategist at BTIG, wrote in a note. "Perhaps most importantly, companies in the region remain more optimistic about the future. While this isn't a foolproof indicator, it is an important gauge of expectations and right now, there is a better tone to sentiment and data."

Citigroup (C - Get Report) kicked of earnings reports this week with a big miss. The lender posted a fourth quarter profit of 38 cents a share on revenue of $17.2 billion, falling well short of the average estimate of 50 cents a share. Wells Fargo (WFC - Get Report), on the other hand, reported quarterly results a little better than forecast with earnings of 73 cents a share on revenue that climbed 20% from last quarter to $8.1 billion. Analysts expected profits of 72 cents a share, according to

In other corporate news, Carnival's (CCL - Get Report) cruise liner Costa Concordia ran aground off the coast of Italy Jan. 13, killing six people, while another 29 passengers remain missing. The ship began taking on water Friday when the vessel deviated from its programed course and struck a reef. The wreck may cost the cruise line-operator's insurers as much as $800 million, according to analysts at Numis Securities. Carnival shares tumbled 23% on Monday in London when the U.S. market remained closed in observance of Martin Luther King, Jr. Day.

Carnival's insurers include Assicurazioni Generali, based in Treste, Italy, London-based RSA Insurance Group, XL Group (XL) and Hannover Re.

Royal Bank of Scotland (RBS - Get Report) said Tuesday it would sell its aircraft leasing division -- RBS Aviation Capital -- to Japan's Sumitomo Mitsui Financial for $7.3 billion. RBS Aviation owns 206 aircraft and has commitments to buy another 87 by 2015, commitments the Japanese company takes on with the purchase, according to The Associated Press.

Ista Pharmaceuticals (ISTA) said it has received a revised non-binding proposal from Valeant Pharmaceuticals (VRX - Get Report) and will consider the updated proposal. Valeant raised its offer to $7.50 a share in cash from $6.50 and has set a target price of $8.50 a share in cash.

February oil futures were rising $2 to $100.70 a barrel, while February gold futures were climbing $33.40 to $1,664.20 an ounce.

The dollar index was dropping 0.8%. The benchmark 10-year Treasury was falling 13/32, diluting the yield to 1.905%.

-- Written by Kaitlyn Kiernan in New York.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CCL $49.24 1.80%
C $44.35 0.27%
RBS $6.24 0.24%
WFC $49.05 0.18%
VRX $31.12 -9.80%


Chart of I:DJI
DOW 17,738.13 +77.42 0.44%
S&P 500 2,056.00 +5.37 0.26%
NASDAQ 4,727.5360 +10.4420 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs